{"id":151369,"date":"2026-07-15T10:05:20","date_gmt":"2026-07-15T04:35:20","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=151369"},"modified":"2026-07-15T10:05:22","modified_gmt":"2026-07-15T04:35:22","slug":"anlon-healthcare-share-price-forecast-next-3-years","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/","title":{"rendered":"Where Will Anlon Healthcare Share Price Be in the Next 3 Years?"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Anlon Healthcare share price Rs 640. 52W high Rs 748, low Rs 335. Market cap Rs 481 Cr. 2030 scenario range Rs 795 to Rs 1,350.<\/em><\/p>\n<p>The <a href=\"https:\/\/univest.in\/user\/stocks\/ahcl\/anlon-healthcare-limited-share-price-today\">Anlon Healthcare<\/a> share price forecast for the next 3 years is a question on many investors&#8217; minds as the stock trades at Rs 640, within a 52 week range of Rs 335 to Rs 748. This article lays out a scenario based Anlon Healthcare share price outlook for 2027, 2028 and 2030, built on the company&#8217;s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=anlon-healthcare-forecast-3yr\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Anlon_Healthcare_Company_Overview\" title=\"Anlon Healthcare Company Overview\">Anlon Healthcare Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Where_Does_Anlon_Healthcare_Share_Price_Stand_Today\" title=\"Where Does Anlon Healthcare Share Price Stand Today?\">Where Does Anlon Healthcare Share Price Stand Today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Anlon_Healthcare_Share_Price_Forecast_Key_Growth_Drivers_for_the_Next_3_Years\" title=\"Anlon Healthcare Share Price Forecast: Key Growth Drivers for the Next 3 Years\">Anlon Healthcare Share Price Forecast: Key Growth Drivers for the Next 3 Years<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Earnings_Trajectory_and_Return_Ratios\" title=\"Earnings Trajectory and Return Ratios\">Earnings Trajectory and Return Ratios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Structural_Tailwinds_in_Indian_Pharmaceuticals\" title=\"Structural Tailwinds in Indian Pharmaceuticals\">Structural Tailwinds in Indian Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Company_Specific_Catalysts\" title=\"Company Specific Catalysts\">Company Specific Catalysts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Macro_Environment_and_Liquidity\" title=\"Macro Environment and Liquidity\">Macro Environment and Liquidity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Anlon_Healthcare_Share_Price_Forecast_2027_2028_and_2030_Scenario_Analysis\" title=\"Anlon Healthcare Share Price Forecast 2027, 2028 and 2030: Scenario Analysis\">Anlon Healthcare Share Price Forecast 2027, 2028 and 2030: Scenario Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Bull_Case_vs_Bear_Case_for_Anlon_Healthcare_Share_Price\" title=\"Bull Case vs Bear Case for Anlon Healthcare Share Price\">Bull Case vs Bear Case for Anlon Healthcare Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#The_Bull_Case\" title=\"The Bull Case\">The Bull Case<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#The_Bear_Case\" title=\"The Bear Case\">The Bear Case<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Key_Risks_That_Could_Change_the_Anlon_Healthcare_Share_Price_Outlook\" title=\"Key Risks That Could Change the Anlon Healthcare Share Price Outlook\">Key Risks That Could Change the Anlon Healthcare Share Price Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Is_Anlon_Healthcare_Worth_Watching_for_the_Long_Term\" title=\"Is Anlon Healthcare Worth Watching for the Long Term?\">Is Anlon Healthcare Worth Watching for the Long Term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_is_the_Anlon_Healthcare_share_price_forecast_for_the_next_3_years\" title=\"What is the Anlon Healthcare share price forecast for the next 3 years?\">What is the Anlon Healthcare share price forecast for the next 3 years?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_is_the_Anlon_Healthcare_share_price_forecast_for_2027\" title=\"What is the Anlon Healthcare share price forecast for 2027?\">What is the Anlon Healthcare share price forecast for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_is_the_Anlon_Healthcare_share_price_forecast_for_2028\" title=\"What is the Anlon Healthcare share price forecast for 2028?\">What is the Anlon Healthcare share price forecast for 2028?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_is_the_current_share_price_of_Anlon_Healthcare\" title=\"What is the current share price of Anlon Healthcare?\">What is the current share price of Anlon Healthcare?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#Is_Anlon_Healthcare_a_good_stock_for_the_long_term\" title=\"Is Anlon Healthcare a good stock for the long term?\">Is Anlon Healthcare a good stock for the long term?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_is_the_Anlon_Healthcare_share_price_outlook_for_2030\" title=\"What is the Anlon Healthcare share price outlook for 2030?\">What is the Anlon Healthcare share price outlook for 2030?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/anlon-healthcare-share-price-forecast-next-3-years\/#What_are_the_key_risks_to_the_Anlon_Healthcare_share_price_forecast\" title=\"What are the key risks to the Anlon Healthcare share price forecast?\">What are the key risks to the Anlon Healthcare share price forecast?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Company_Overview\"><\/span><strong>Anlon Healthcare Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Anlon Healthcare manufactures pharmaceutical intermediates and active pharmaceutical ingredients for domestic and export formulators. Understanding the business model is the first step in framing any credible Anlon Healthcare share price forecast, because the durability of earnings ultimately decides where the stock trades.<\/p>\n<table>\n<tbody>\n<tr>\n<td><strong>Company<\/strong><\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/anlon\/anlon-technology-solution-ltd-share-price-today\">Anlon Healthcare<\/a><\/td>\n<\/tr>\n<tr>\n<td><strong>NSE Ticker<\/strong><\/td>\n<td>ANLON<\/td>\n<\/tr>\n<tr>\n<td><strong>CMP<\/strong><\/td>\n<td>Rs 640<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week High<\/strong><\/td>\n<td>Rs 748<\/td>\n<\/tr>\n<tr>\n<td><strong>52 Week Low<\/strong><\/td>\n<td>Rs 335<\/td>\n<\/tr>\n<tr>\n<td><strong>Market Cap<\/strong><\/td>\n<td>Rs 481 Cr<\/td>\n<\/tr>\n<tr>\n<td><strong>Stock PE<\/strong><\/td>\n<td>34.6<\/td>\n<\/tr>\n<tr>\n<td><strong>Book Value<\/strong><\/td>\n<td>Rs 116<\/td>\n<\/tr>\n<tr>\n<td><strong>ROE<\/strong><\/td>\n<td>21.1%<\/td>\n<\/tr>\n<tr>\n<td><strong>ROCE<\/strong><\/td>\n<td>27.1%<\/td>\n<\/tr>\n<tr>\n<td><strong>Dividend Yield<\/strong><\/td>\n<td>0%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Where_Does_Anlon_Healthcare_Share_Price_Stand_Today\"><\/span><strong>Where Does Anlon Healthcare Share Price Stand Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The stock currently trades about 14 percent below its 52 week high of Rs 748, which means the market has already tempered some of its optimism. For anyone building a Anlon Healthcare share price forecast, this correction matters for the Anlon Healthcare share price forecast starting point, because entry valuations have a large bearing on 3 year returns.<\/p>\n<p>At the current price, Anlon Healthcare commands a market capitalisation of Rs 481 Cr and trades at a price to earnings multiple of 34.6. The company generates a return on equity of 21.1% and a return on capital employed of 27.1%, which places it in the category of businesses with strong return ratios. These numbers anchor the Anlon Healthcare share price forecast scenarios that follow. How the broader <a href=\"https:\/\/univest.in\/indices\/nifty-50\/nifty-50-share-price-today\">Nifty 50<\/a> index trades over this period will also influence the multiple investors are willing to assign to the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Share_Price_Forecast_Key_Growth_Drivers_for_the_Next_3_Years\"><\/span><strong>Anlon Healthcare Share Price Forecast: Key Growth Drivers for the Next 3 Years<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four forces are likely to shape the Anlon Healthcare share price forecast between now and 2030, and together they explain most of the dispersion in this Anlon Healthcare share price forecast. Each is discussed below with its likely direction of impact.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_Trajectory_and_Return_Ratios\"><\/span><strong>Earnings Trajectory and Return Ratios<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Stock prices ultimately follow earnings. With strong return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Anlon Healthcare share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Tailwinds_in_Indian_Pharmaceuticals\"><\/span><strong>Structural Tailwinds in Indian Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Indian pharmaceutical market continues to grow in high single to low double digits, supported by chronic disease prevalence, better diagnosis rates and premiumisation of therapies. Companies with strong brand equity and field force productivity, like Anlon Healthcare, are positioned to grow ahead of the market. Sector trends are visible in the <a href=\"https:\/\/univest.in\/indices\/nifty-pharma\/nifty-pharma-share-price-today\">Nifty Pharma<\/a> index, which serves as a useful barometer for the space.<\/p>\n<p>Within the space, investors often benchmark Anlon Healthcare against peers such as <a href=\"https:\/\/univest.in\/stocks\/alpa\/alpa-laboratories-ltd-share-price-today\">Alpa Laboratories<\/a>, <a href=\"https:\/\/univest.in\/stocks\/amanta\/amanta-healthcare-ltd-share-price-today\">Amanta Healthcare<\/a> and <a href=\"https:\/\/univest.in\/stocks\/aareydrugs\/aarey-drugs-and-pharmaceuticals-ltd-share-price-today\">Aarey Drugs &amp; Pharmaceuticals<\/a> on growth and valuations before forming a view on the Anlon Healthcare share price forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Company_Specific_Catalysts\"><\/span><strong>Company Specific Catalysts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The bull case for Anlon Healthcare rests on rising demand for pharma intermediates from domestic and export formulators and new product additions. If these play out on schedule, the Anlon Healthcare share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Macro_Environment_and_Liquidity\"><\/span><strong>Macro Environment and Liquidity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Anlon Healthcare share price forecast, while global risk aversion would do the opposite to the Anlon Healthcare share price outlook.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anlon_Healthcare_Share_Price_Forecast_2027_2028_and_2030_Scenario_Analysis\"><\/span><strong>Anlon Healthcare Share Price Forecast 2027, 2028 and 2030: Scenario Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below presents a scenario based Anlon Healthcare share price forecast using compounded annual growth assumptions applied to the current market price of Rs 640. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.<\/p>\n<table>\n<thead>\n<tr>\n<th>Year<\/th>\n<th>Bear Case<\/th>\n<th>Base Case<\/th>\n<th>Bull Case<\/th>\n<th>Assumption<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>2027<\/td>\n<td>Rs 690<\/td>\n<td>Rs 760<\/td>\n<td>Rs 820<\/td>\n<td>5% to 18% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2028<\/td>\n<td>Rs 725<\/td>\n<td>Rs 850<\/td>\n<td>Rs 970<\/td>\n<td>5% to 18% CAGR on CMP<\/td>\n<\/tr>\n<tr>\n<td>2030<\/td>\n<td>Rs 795<\/td>\n<td>Rs 1,070<\/td>\n<td>Rs 1,350<\/td>\n<td>5% to 18% CAGR on CMP<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the base case scenario of this Anlon Healthcare share price forecast, the 2030 level works out to roughly Rs 1,070, implying steady compounding from today&#8217;s levels. The bull case of Rs 1,350 assumes rising demand for pharma intermediates from domestic and export formulators and new product additions delivers ahead of expectations, while the bear case of Rs 795 captures a scenario where growth stalls. That is an outcome band of about 24 percent to 111 percent over the period.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/sebi-registered-investment-advisor-india\"><strong>Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_vs_Bear_Case_for_Anlon_Healthcare_Share_Price\"><\/span><strong>Bull Case vs Bear Case for Anlon Healthcare Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"The_Bull_Case\"><\/span><strong>The Bull Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The optimistic Anlon Healthcare share price forecast assumes rising demand for pharma intermediates from domestic and export formulators and new product additions. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 1,350 by 2030.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"The_Bear_Case\"><\/span><strong>The Bear Case<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The cautious view centres on the fact that client concentration and pricing pressure in commodity pharma intermediates are key risks. If these pressures dominate, the Anlon Healthcare share price forecast would skew toward the lower band and the stock could stagnate near Rs 795 even by 2030, underperforming broader indices.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Change_the_Anlon_Healthcare_Share_Price_Outlook\"><\/span><strong>Key Risks That Could Change the Anlon Healthcare Share Price Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Execution risk:<\/strong> Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Anlon Healthcare share price forecast.<\/li>\n<li><strong>Valuation risk:<\/strong> At a PE of 34.6, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.<\/li>\n<li><strong>Sector risk:<\/strong> Client concentration and pricing pressure in commodity pharma intermediates are key risks.<\/li>\n<li><strong>Macro risk:<\/strong> A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.<\/li>\n<li><strong>Regulatory risk:<\/strong> Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Is_Anlon_Healthcare_Worth_Watching_for_the_Long_Term\"><\/span><strong>Is Anlon Healthcare Worth Watching for the Long Term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>For long term investors, the relevant question is not just where the Anlon Healthcare share price forecast lands in 2030 or what any single Anlon Healthcare share price forecast says today, but whether the business can compound capital through cycles. The company&#8217;s positioning around rising demand for pharma intermediates from domestic and export formulators and new product additions gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.<\/p>\n<p>Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Anlon Healthcare share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Anlon Healthcare share price live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Anlon Healthcare share price forecast for the next 3 years spans Rs 795 to Rs 1,350 by 2030 under the scenarios discussed, with a base case near Rs 1,070. Any credible Anlon Healthcare share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising demand for pharma intermediates from domestic and export formulators and new product additions and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anlon_Healthcare_share_price_forecast_for_the_next_3_years\"><\/span><strong>What is the Anlon Healthcare share price forecast for the next 3 years?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Anlon Healthcare share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 795 in the bear case to Rs 1,350 in the bull case, with a base case near Rs 1,070, depending on earnings delivery and market conditions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anlon_Healthcare_share_price_forecast_for_2027\"><\/span><strong>What is the Anlon Healthcare share price forecast for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> For 2027, the scenario range works out to Rs 690 to Rs 820, with a base case around Rs 760. This assumes compounding on the current price of Rs 640 and is illustrative, not a guaranteed outcome.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anlon_Healthcare_share_price_forecast_for_2028\"><\/span><strong>What is the Anlon Healthcare share price forecast for 2028?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2028 scenario range is Rs 725 to Rs 970, with the base case near Rs 850. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Anlon_Healthcare\"><\/span><strong>What is the current share price of Anlon Healthcare?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anlon Healthcare currently trades at around Rs 640 on the NSE, within a 52 week range of Rs 335 to Rs 748. Prices change continuously during market hours, so check live quotes before acting.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Anlon_Healthcare_a_good_stock_for_the_long_term\"><\/span><strong>Is Anlon Healthcare a good stock for the long term?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anlon Healthcare has a credible long term story built on rising demand for pharma intermediates from domestic and export formulators and new product additions, but it also carries risks since client concentration and pricing pressure in commodity pharma intermediates are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anlon_Healthcare_share_price_outlook_for_2030\"><\/span><strong>What is the Anlon Healthcare share price outlook for 2030?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Anlon Healthcare share price outlook for 2030 spans Rs 795 to Rs 1,350 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Anlon_Healthcare_share_price_forecast\"><\/span><strong>What are the key risks to the Anlon Healthcare share price forecast?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are execution delays, valuation compression from the current PE of 34.6, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Anlon Healthcare share price forecast for the next 3 years points to a scenario range of Rs 795 to Rs 1,350 by 2030, driven by rising demand for pharma intermediates from domestic and export formulators and new product additions and sector tailwinds.<\/p>\n","protected":false},"author":34,"featured_media":151846,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-151369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1784090124:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["76"],"rank_math_title":["Anlon Healthcare Share Price Forecast: 3 Year Outlook to 2030"],"rank_math_description":["Where will Anlon Healthcare share price be in the next 3 years? Detailed Anlon Healthcare share price forecast with 2027, 2028 and 2030 scenarios, growth drivers and risks."],"rank_math_focus_keyword":["Anlon Healthcare share price forecast"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-07-14"],"_thumbnail_id":["151846"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["26321"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/Where-Will-Anlon-Healthcare-Share-Price-Be-in-the-Next-3-Years.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/151369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=151369"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/151369\/revisions"}],"predecessor-version":[{"id":151847,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/151369\/revisions\/151847"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/151846"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=151369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=151369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=151369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}